Clinical Trial Update: Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic Hypotension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mannitol during hemodialysis initiation to reduce intra-dialytic hypotension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Mannitol (mannitol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Intra-dialytic Hypotension | Phase 2 | Status: COMPLETED | Results posted: 2017-10-19